SILO Silo Pharma, Inc.

Nasdaq silopharma.com


$ 0.60 $ -0.02 (-3.23 %)    

Thursday, 16-Oct-2025 11:50:05 EDT
QQQ $ 603.16 $ -2.03 (-0.34 %)
DIA $ 462.10 $ -1.27 (-0.27 %)
SPY $ 664.40 $ -2.49 (-0.37 %)
TLT $ 90.90 $ 0.40 (0.44 %)
GLD $ 393.15 $ 2.00 (0.51 %)
$ 0.66
$ 0.61
$ 0.60 x 100
$ 0.61 x 1,500
$ 0.60 - $ 0.62
$ 0.41 - $ 3.37
2,729,804
na
4.14M
$ -8.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-25-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-24-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-01-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-20-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 04-04-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-13-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-17-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 09-30-2016 06-30-2016 10-Q
38 08-31-2016 03-31-2016 10-Q
39 06-14-2016 12-31-2015 10-K
40 11-20-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 silo-pharma-announces-initial-purchase-of-bitcoin

SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or "the Company), a dive...

 silo-pharma-invests-in-desci-innovation-with-purchase-of-researchhubs-native-token-co-founded-by-coinbase-ceo-brian-armstrong

Company invests in DeSci blockchain innovation and purchases native coin of ResearchHub, a decentralized science platform co-fo...

 silo-pharma-secures-australian-patent-for-ptsd-treatment-spc-15-through-columbia-university-partnership

Silo Pharma, Inc.

 silo-pharma-announces-peer-reviewed-publication-of-spc-14-preclinical-data-for-alzheimers-disease-in-alzheimers-research--therapy-ceo-weisblum-cites-potential-for-targeted-dementia-therapies

Manuscript featured in leading open-access scientific journal Alzheimer's Research & TherapySARASOTA, FL, Aug. 21, 2025...

 silo-pharma-completes-dosing-in-fda-requested-7-day-safety-and-toxicology-large-animal-study-of-spc-15

Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focu...

Core News & Articles

*Hoth Therapeutics and Silo Pharma Launch Joint Venture to Commercialize VA-Invented Obesity Drug Targeting $100B+ Global Marke...

 us-stocks-likely-to-open-on-a-mixed-note-after-sp-500-scales-6000-mark-whole-globe-is-in-a-bull-market

U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION